4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
5.55
-0.26 (-4.48%)
At close: Dec 27, 2024, 4:00 PM
5.56
+0.01 (0.18%)
After-hours: Dec 27, 2024, 4:54 PM EST
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $256.56 million as of December 27, 2024. Its market cap has decreased by -62.49% in one year.
Market Cap
256.56M
Enterprise Value
-269.27M
1-Year Change
-62.49%
Ranking
Category
Stock Price
$5.55
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $256.56M, a decrease of -55.79%. That is a compound annual growth rate of -18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 256.56M | -70.38% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sera Prognostics | 273.56M |
| TruBridge | 272.44M |
| Pulmonx | 271.68M |
| OraSure Technologies | 271.52M |
| iTeos Therapeutics | 270.53M |
| AC Immune | 267.63M |
| Zynex | 264.95M |
| Bright Minds Biosciences | 261.45M |